Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 212 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Lurbinectedin Zongertinib Shows Durable Antitumour Activity in First-Line Treatment for Patients with Previously Untreated HER2-mutated Advanced NSCLC Patient Guide on Immunotherapy Side Effects and Their Management Now Available Also in the Ukrainian MOST POPULAR Speaking with One Cancer Voice for cancer patients in England March 29, 2023 New on NCI’s Website for July 2023 – Researcher/Trainee Special Edition July 21, 2023 Let’s talk about HPV: 6 common questions answered June 16, 2021 How Financial Toxicity Can Impact Cancer Caregivers and Where to Find... August 23, 2022 Load more HOT NEWS Identical Twins Find Strength in Shared Breast Cancer Battle After Being... Ifosfamide May Be Treatment of Choice for Some People with Ewing... Ventana HER2 Dual ISH Assay, A New Diagnostic Tool From Roche,... For Women With Dense Breasts, An MRI May Be A Better...
